Development of Monoclonal Antibody Therapeutics for Anthrax
Development of Monoclonal Antibody Therapeutics for Anthrax
炭疽单克隆抗体疗法的开发
批准号：
7696712
负责人：
金额：
$531.28万
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-09-01 至 2012-08-31
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This contract supports the advanced development of AVP-21D9 as a therapeutic for the treatment of anthrax. The scope of work for this contract includes preclinical and clinical development activities that fall into the following areas: IND-enabling activities; manufacturing activities; animal study activities; and BLA-enabling activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
